StockMarketWire.com - Omega Diagnostics said results for the year to 31 March 2015 will be in line with market expectations.

Revenues for the year are expected to be £12.1m and adjusted profit before tax (before acquisition costs, share based payments, IFRS-related discount unwinds and amortisation of intangible assets) will be significantly higher than that achieved in the prior year and is expected to be approximately £1.4m.






Story provided by StockMarketWire.com